Putnam Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-75,767
| Closed | -$4.03M | – | 1179 |
|
|
2022
Q3 | $4.03M | Sell |
75,767
-10,096
| -12% | -$537K | 0.01% | 485 |
|
|
2022
Q2 | $5.01M | Buy |
85,863
+19,121
| +29% | +$1.11M | 0.01% | 439 |
|
|
2022
Q1 | $5.09M | Buy |
+66,742
| New | +$5.09M | 0.01% | 494 |
|
|
2018
Q2 | – | Sell |
-464,039
| Closed | -$14.5M | – | 1161 |
|
|
2018
Q1 | $14.5M | Sell |
464,039
-172,149
| -27% | -$5.36M | 0.03% | 317 |
|
|
2017
Q4 | $29M | Sell |
636,188
-9,876
| -2% | -$451K | 0.06% | 225 |
|
|
2017
Q3 | $24.3M | Sell |
646,064
-8,110
| -1% | -$305K | 0.06% | 239 |
|
|
2017
Q2 | $31.2M | Buy |
654,174
+187,558
| +40% | +$8.95M | 0.07% | 210 |
|
|
2017
Q1 | $21.3M | Buy |
466,616
+432,067
| +1,251% | +$19.7M | 0.05% | 276 |
|
|
2016
Q4 | $1.12M | Buy |
34,549
+5,410
| +19% | +$175K | ﹤0.01% | 983 |
|
|
2016
Q3 | $997K | Sell |
29,139
-53,772
| -65% | -$1.84M | ﹤0.01% | 1021 |
|
|
2016
Q2 | $2.8M | Buy |
82,911
+41,377
| +100% | +$1.4M | 0.01% | 832 |
|
|
2016
Q1 | $2.2M | Sell |
41,534
-32,585
| -44% | -$1.73M | 0.01% | 924 |
|
|
2015
Q4 | $5.69M | Sell |
74,119
-76,981
| -51% | -$5.91M | 0.01% | 617 |
|
|
2015
Q3 | $6.21M | Sell |
151,100
-41,662
| -22% | -$1.71M | 0.01% | 596 |
|
|
2015
Q2 | $13.6M | Buy |
192,762
+18,592
| +11% | +$1.31M | 0.03% | 402 |
|
|
2015
Q1 | $15.5M | Buy |
+174,170
| New | +$15.5M | 0.03% | 394 |
|